Cargando…
The Potential of Neoagaro-Oligosaccharides as a Treatment of Type II Diabetes in Mice
Type 2 diabetes mellitus (T2DM) accounts for more than 90% of cases of diabetes mellitus, which is harmful to human health. Herein, neoagaro-oligosaccharides (NAOs) were prepared and their potential as a treatment of T2DM was evaluated in KunMing (KM) mice. Specifically, a T2DM mice model was establ...
Autores principales: | Lin, Fudi, Yang, Dongda, Huang, Yayan, Zhao, Yan, Ye, Jing, Xiao, Meitian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835453/ https://www.ncbi.nlm.nih.gov/pubmed/31547097 http://dx.doi.org/10.3390/md17100541 |
Ejemplares similares
-
Quantification of Neoagaro-Oligosaccharide Production through Enzymatic Hydrolysis and Its Anti-Oxidant Activities
por: Xu, Shu-Ying, et al.
Publicado: (2018) -
Production of Neoagaro-Oligosaccharides With Various Degrees of Polymerization by Using a Truncated Marine Agarase
por: Qu, Wu, et al.
Publicado: (2020) -
Neoagaro-Oligosaccharides Ameliorate Chronic Restraint Stress-Induced Depression by Increasing 5-HT and BDNF in the Brain and Remodeling the Gut Microbiota of Mice
por: Zhuang, Yan, et al.
Publicado: (2022) -
Neoagaro-oligosaccharide monomers inhibit inflammation in LPS-stimulated macrophages through suppression of MAPK and NF-κB pathways
por: Wang, Wei, et al.
Publicado: (2017) -
Anti-obesity effect of Neoagaro-oligosaccharides with overweight and obese subjects: a 16-week, randomized, double-blind, placebo-controlled clinical trial
por: Baek, Hyang-Im, et al.
Publicado: (2023)